The Goldman Sachs Group, Inc. 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:40 pm Sale | 2022-12-30 | 13G | QUOIN PHARMACEUTICALS LTD QNRX | GOLDMAN SACHS GROUP INC GS | 4 0.000% | -120,875 (-100.00%) | Filing |